The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis.

The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis.

Item
http://www.wikidata.org/entity/Q36980174
Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.The economic burden of TNFα inhibitors and other biologic treatments in Norway.Etanercept in the treatment of recalcitrant enteropathic arthritis: a case report.Cost-utility analysis of antihypertensive medications in Nigeria: a decision analysis.Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitors.Systematic review of drug administration costs and implications for biopharmaceutical manufacturing.Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries.Impact of small study bias on cost-effectiveness acceptability curves and value of information analyses.Etanercept prevents airway hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigsMultiparameter evidence synthesis in epidemiology and medical decision-making.Cost-effectiveness analysis: discount the placebo at your peril.A mathematical analysis of rebound in a target-mediated drug disposition model: I.without feedback.Intra-operative vs pre-operative endoscopic sphincterotomy in patients with gallbladder and common bile duct stones: cost-utility and value-of-information analysis.Cost-effectiveness analysis of secukinumab for the treatment of active psoriatic arthritis: a Canadian perspective.Cost effectiveness of golimumab for the treatment of active psoriatic arthritis.
P2860

The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis.

Item
http://www.wikidata.org/entity/Q36980174
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The cost-effectiveness of etan ...... ents with psoriatic arthritis.
@en
type
label
The cost-effectiveness of etan ...... ents with psoriatic arthritis.
@en
prefLabel
The cost-effectiveness of etan ...... ents with psoriatic arthritis.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
The cost-effectiveness of etan ...... ents with psoriatic arthritis.
@en
P2093
P304
P31
P356
10.1093/RHEUMATOLOGY/KEM221
P433
P478
P50
P577
P698